Spyre Therapeutics, Inc. SYRE Common Stock Shares Issued
Common Stock Shares Issued at other companies
Other financials
Where this comes from
Reported directly by Spyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Spyre Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Spyre Therapeutics, Inc.'s common stock shares issued.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Spyre Therapeutics, Inc.'s common stock shares issued?
- Spyre Therapeutics, Inc. (SYRE) reported common stock shares issued of 78.8M in Q1 2026.
- How has Spyre Therapeutics, Inc.'s common stock shares issued changed year-over-year?
- Spyre Therapeutics, Inc.'s common stock shares issued increased by 30.8% year-over-year, from 60.3M to 78.8M.
- What is the long-term trend for Spyre Therapeutics, Inc.'s common stock shares issued?
- Over 3 years (2022 to 2025), Spyre Therapeutics, Inc.'s common stock shares issued has grown at a 210.4% compound annual growth rate (CAGR), from 2.6M to 78.2M.
- What does common stock shares issued mean?
- The total number of shares that have been authorized and distributed by the corporation since its inception. This includes shares held by the public (outstanding) as well as any shares that the company has repurchased and holds in its treasury. It represents the historical volume of equity capital creation.